Fenfluramine in CDKL5 Deficiency Disorder (CDD)
Clinical trial NCT03861871 · COMPLETED
Trial details
- NCT number
- NCT03861871
- Sponsor
- NYU Langone Health
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-29
- Primary completion
- 2022-08-30
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.